.svg)
.webp)
.webp)
.png)
.avif)
.png)
.webp)
.webp)
.webp)
Lorem ipsum dolor sit amet consectetur. Dictumst faucibus nibh imperdiet phasellus vitae ut sit. Ut eros amet massa tellus orci. Vestibulum ac arcu est nulla non eget nulla. Eget pulvinar eu ac mi cursus elementum neque. Massa nisl fringilla platea diam faucibus nullam. In lacus mauris nec ultrices. Ut accumsan leo adipiscing montes proin.
In this keynote session, Dr Ma'ayan delves into the transformative impact of generative AI and LLMs in the analysis of gene sets. He discusses how these innovations are enhancing gene annotation prediction, ultimately leading to the discovery of novel therapeutic targets across a broad spectrum of biomedical research applications.
.webp)
Lorem ipsum dolor sit amet consectetur. Dictumst faucibus nibh imperdiet phasellus vitae ut sit. Ut eros amet massa tellus orci. Vestibulum ac arcu est nulla non eget nulla. Eget pulvinar eu ac mi cursus elementum neque. Massa nisl fringilla platea diam faucibus nullam. In lacus mauris nec ultrices. Ut accumsan leo adipiscing montes proin.
In this keynote session, Dr Ma'ayan delves into the transformative impact of generative AI and LLMs in the analysis of gene sets. He discusses how these innovations are enhancing gene annotation prediction, ultimately leading to the discovery of novel therapeutic targets across a broad spectrum of biomedical research applications.
Lorem ipsum dolor sit amet consectetur. Dictumst faucibus nibh imperdiet phasellus vitae ut sit. Ut eros amet massa tellus orci. Vestibulum ac arcu est nulla non eget nulla. Eget pulvinar eu ac mi cursus elementum neque. Massa nisl fringilla platea diam faucibus nullam. In lacus mauris nec ultrices. Ut accumsan leo adipiscing montes proin.
In this keynote session, Dr Ma'ayan delves into the transformative impact of generative AI and LLMs in the analysis of gene sets. He discusses how these innovations are enhancing gene annotation prediction, ultimately leading to the discovery of novel therapeutic targets across a broad spectrum of biomedical research applications.
%201.webp)
Lorem ipsum dolor sit amet consectetur. Dictumst faucibus nibh imperdiet phasellus vitae ut sit. Ut eros amet massa tellus orci. Vestibulum ac arcu est nulla non eget nulla. Eget pulvinar eu ac mi cursus elementum neque. Massa nisl fringilla platea diam faucibus nullam. In lacus mauris nec ultrices. Ut accumsan leo adipiscing montes proin.
In this keynote session, Dr Ma'ayan delves into the transformative impact of generative AI and LLMs in the analysis of gene sets. He discusses how these innovations are enhancing gene annotation prediction, ultimately leading to the discovery of novel therapeutic targets across a broad spectrum of biomedical research applications.
Lorem ipsum dolor sit amet consectetur. Dictumst faucibus nibh imperdiet phasellus vitae ut sit. Ut eros amet massa tellus orci. Vestibulum ac arcu est nulla non eget nulla. Eget pulvinar eu ac mi cursus elementum neque. Massa nisl fringilla platea diam faucibus nullam. In lacus mauris nec ultrices. Ut accumsan leo adipiscing montes proin.
In this keynote session, Dr Ma'ayan delves into the transformative impact of generative AI and LLMs in the analysis of gene sets. He discusses how these innovations are enhancing gene annotation prediction, ultimately leading to the discovery of novel therapeutic targets across a broad spectrum of biomedical research applications.
Lorem ipsum dolor sit amet consectetur. Dictumst faucibus nibh imperdiet phasellus vitae ut sit. Ut eros amet massa tellus orci. Vestibulum ac arcu est nulla non eget nulla. Eget pulvinar eu ac mi cursus elementum neque. Massa nisl fringilla platea diam faucibus nullam. In lacus mauris nec ultrices. Ut accumsan leo adipiscing montes proin.
In this keynote session, Dr Ma'ayan delves into the transformative impact of generative AI and LLMs in the analysis of gene sets. He discusses how these innovations are enhancing gene annotation prediction, ultimately leading to the discovery of novel therapeutic targets across a broad spectrum of biomedical research applications.
Vast Literature vs. Context-Rich Data – What’s the Roadmap
What roadmap and architectural bets are required to bridge the gap between vast public literature and context-rich proprietary data?
.webp)
Lorem ipsum dolor sit amet consectetur. Dictumst faucibus nibh imperdiet phasellus vitae ut sit. Ut eros amet massa tellus orci. Vestibulum ac arcu est nulla non eget nulla. Eget pulvinar eu ac mi cursus elementum neque. Massa nisl fringilla platea diam faucibus nullam. In lacus mauris nec ultrices. Ut accumsan leo adipiscing montes proin.
In this keynote session, Dr Ma'ayan delves into the transformative impact of generative AI and LLMs in the analysis of gene sets. He discusses how these innovations are enhancing gene annotation prediction, ultimately leading to the discovery of novel therapeutic targets across a broad spectrum of biomedical research applications.
Lorem ipsum dolor sit amet consectetur. Dictumst faucibus nibh imperdiet phasellus vitae ut sit. Ut eros amet massa tellus orci. Vestibulum ac arcu est nulla non eget nulla. Eget pulvinar eu ac mi cursus elementum neque. Massa nisl fringilla platea diam faucibus nullam. In lacus mauris nec ultrices. Ut accumsan leo adipiscing montes proin.
In this keynote session, Dr Ma'ayan delves into the transformative impact of generative AI and LLMs in the analysis of gene sets. He discusses how these innovations are enhancing gene annotation prediction, ultimately leading to the discovery of novel therapeutic targets across a broad spectrum of biomedical research applications.
Lorem ipsum dolor sit amet consectetur. Dictumst faucibus nibh imperdiet phasellus vitae ut sit. Ut eros amet massa tellus orci. Vestibulum ac arcu est nulla non eget nulla. Eget pulvinar eu ac mi cursus elementum neque. Massa nisl fringilla platea diam faucibus nullam. In lacus mauris nec ultrices. Ut accumsan leo adipiscing montes proin.
In this keynote session, Dr Ma'ayan delves into the transformative impact of generative AI and LLMs in the analysis of gene sets. He discusses how these innovations are enhancing gene annotation prediction, ultimately leading to the discovery of novel therapeutic targets across a broad spectrum of biomedical research applications.
Lorem ipsum dolor sit amet consectetur. Dictumst faucibus nibh imperdiet phasellus vitae ut sit. Ut eros amet massa tellus orci. Vestibulum ac arcu est nulla non eget nulla. Eget pulvinar eu ac mi cursus elementum neque. Massa nisl fringilla platea diam faucibus nullam. In lacus mauris nec ultrices. Ut accumsan leo adipiscing montes proin.
In this keynote session, Dr Ma'ayan delves into the transformative impact of generative AI and LLMs in the analysis of gene sets. He discusses how these innovations are enhancing gene annotation prediction, ultimately leading to the discovery of novel therapeutic targets across a broad spectrum of biomedical research applications.
.webp)
Lorem ipsum dolor sit amet consectetur. Dictumst faucibus nibh imperdiet phasellus vitae ut sit. Ut eros amet massa tellus orci. Vestibulum ac arcu est nulla non eget nulla. Eget pulvinar eu ac mi cursus elementum neque. Massa nisl fringilla platea diam faucibus nullam. In lacus mauris nec ultrices. Ut accumsan leo adipiscing montes proin.
In this keynote session, Dr Ma'ayan delves into the transformative impact of generative AI and LLMs in the analysis of gene sets. He discusses how these innovations are enhancing gene annotation prediction, ultimately leading to the discovery of novel therapeutic targets across a broad spectrum of biomedical research applications.
What Bold AI Bets does a Pharma need for a Reset?
Continue the conversation at the post-event gathering.
Extend the conversation! Join us for an informal networking session with complimentary drinks and endless conversations. It's the perfect way to wrap up the day and build lasting connections.
.webp)
CEO at Elucidata
.webp)
VP Copilot Reasoning at Microsoft
Head, AI/ML, Takeda
Group Discussion 1:
Group Discussion 2
Lorem ipsum dolor sit amet consectetur. Dictumst faucibus nibh imperdiet phasellus vitae ut sit. Ut eros amet massa tellus orci. Vestibulum ac arcu est nulla non eget nulla. Eget pulvinar eu ac mi cursus elementum neque. Massa nisl fringilla platea diam faucibus nullam. In lacus mauris nec ultrices. Ut accumsan leo adipiscing montes proin.
Ideal for Data & AI leaders leading initiatives in life sciences. These include:
.svg)
R&D, Translational Research, and Scientific Informatics Leaders
AI/ML, Data Science, and Digital Health Teams
Computational Biologists and Bioinformaticians
TechBio Strategists and Biotech Founders
Product, Data, and Innovation Leads
Clinical & Real-World Data Architects
Lorem ipsum dolor sit amet consectetur. Dictumst faucibus nibh imperdiet phasellus vitae ut sit. Ut eros amet massa tellus orci. Vestibulum ac arcu est nulla non eget nulla. Eget pulvinar eu ac mi cursus elementum neque. Massa nisl fringilla platea diam faucibus nullam. In lacus mauris nec ultrices. Ut accumsan leo adipiscing montes proin.
Designing Agentic AI Systems That Think Like Scientists
Curating Metadata At Scale Without Losing Quality
Using Foundation Models to Accelerate Drug Discovery
Why Natural Language Querying(NLQs) Unlock Adoption
What Scientific Creativity Looks Like in the Age of AI
Informing Portfolio Strategy with AI-Ready Intel
.svg)
%202.svg){kind=icon}
%203.svg){kind=icon}
.svg)
.svg)
.svg)
%201%20(1).svg)
%20(1).svg)
%201%20(1).svg)
.svg)
%201.svg){kind=icon}
.webp)
.webp)
.webp)
.webp)
.webp)
.webp)
.svg)
.webp)
.webp)
.webp){kind=spacer}
.webp){kind=spacer}
